Xc− inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Xc− inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism

Published:2015-11 Issue:1 Volume:368 Page:88-96
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Ma Ming-zhe,Chen Gang,Wang Peng,Lu Wen-hua,Zhu Chao-feng,Song Ming,Yang Jing,Wen Shijun,Xu Rui-hua,Hu Yumin,Huang Peng

Funder

National Natural Science Foundation of China

National Basic Research Program of China

Guangzhou Innovative Research Program

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference46 articles.

1. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial;Koizumi;Lancet Oncol,2008

2. Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer. Scottish Gynaecological Cancer Trials Group;Vasey;J. Clin. Oncol,1999

3. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer;Giacchetti;J. Clin. Oncol,2000

4. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world;Kamangar;J. Clin. Oncol,2006

5. Sixty years of CA: a cancer journal for clinicians;Gansler;CA Cancer J. Clin,2010

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis: Molecular perspective, cellular influence, cancer manifestation, and therapeutic potentials;Journal of Drug Delivery Science and Technology;2024-10

2. UBR5 mediates colorectal cancer chemoresistance by attenuating ferroptosis via Lys 11 ubiquitin-dependent stabilization of Smad3-SLC7A11 signaling;Redox Biology;2024-10

3. Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications;Cancer Letters;2024-08

4. Nanozyme-based cancer theranostics: A scientometric analysis and comprehensive review;Nano Today;2024-08

5. CircDUSP22 Attenuates the Ferroptosis of Prostate Cancer Cells via miR-18a-5p/SLC7A11/GPX4 Signaling;Combinatorial Chemistry & High Throughput Screening;2024-07-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3